Brief: MEI Pharma Announces 1-For-20 Reverse Stock Split
14/04/2023 21:16
April 14 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA ANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT
* MEI PHARMA INC- REVERSE STOCK SPLIT WAS APPROVED BY MEI'S
STOCKHOLDERS ON JANUARY 5, 2023
Source text for Eikon: ID:nBw1HHbNLa
Further company coverage: MEIP.O
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations